Russell D, Baik D, Jordan L, Dooley F, Hummel SL, Prigerson HG, Bowles KH, Creber RMasterson.
2019.
Factors Associated With Live Discharge of Heart Failure Patients From Hospice: A Multimethod Study.. JACC Heart Fail. 7(7):550-557.
Stiles BM, Mao J, Harrison S, Lee B, Port JL, Sedrakyan A, Altorki NK.
2019.
Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.. J Thorac Cardiovasc Surg. 157(6):2454-2465.e1.
Tagawa ST, Antonarakis ES, Gjyrezi A, Galletti G, Kim S, Worroll D, Stewart J, Zaher A, Szatrowski TP, Ballman KV et al..
2019.
Expression of AR-V7 and ARv in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.. Clin Cancer Res. 25(6):1880-1888.
Ghomrawi HMK, Alexiades M, Pavlov H, Nam D, Endo Y, Mandl LA, Mushlin AI.
2014.
Evaluation of two appropriateness criteria for total knee replacement.. Arthritis Care Res (Hoboken). 66(11):1749-53.
Berry K, Pesko MF, Hesdorffer DC, Shellhaas RA, Seirup JK, Grinspan ZM.
2017.
An evaluation of national birth certificate data for neonatal seizure epidemiology.. Epilepsia. 58(3):446-455.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.
2019.
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Creber RMMasterso, Grossman LV, Ryan B, Qian M, Polubriaginof FCG, Restaino S, Bakken S, Hripcsak G, Vawdrey DK.
2019.
Engaging hospitalized patients with personalized health information: a randomized trial of an inpatient portal.. J Am Med Inform Assoc. 26(2):115-123.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..
2020.
Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..
2020.
Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al..
2019.
Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.
Ryan AM, Burgess JF, Pesko MF, Borden WB, Dimick JB.
2015.
The early effects of Medicare's mandatory hospital pay-for-performance program.. Health Serv Res. 50(1):81-97.